Evaluation of Unitaid’s portfolio of COVID-19 investments
Item Details:
- Organisation: World Health Organization
- Reference Number: UNITAID/P/0005323
- Published: 01-Apr-2021
- Deadline: 29-Apr-2021 at 17:00 hours
- Time zone: (GMT 2.00) Brussels, Copenhagen, Madrid, Paris
- Street: Chemin du Pommier 40, Grand-Saconnex
- City: Geneva
- Country: Switzerland
- Zip/Postal Code: 1218
- Expires: This ad has expired
Item Description:
The World Health Organization (WHO) was established in 1948 as a specialized agency of the United Nations. The objective of WHO (www.who.int) is the attainment by all peoples of the highest possible level of health. “Health”, as defined in the WHO Constitution, is a state of complete physical, mental and social well being and not merely the absence of disease or infirmity. WHO’s main function is to act as the directing and coordinating authority on international health work.
The WHO Secretariat consists of some 8,400 staff at the Organization’s headquarters in Geneva, in the six regional offices and in countries. The Secretariat is headed by the Director-General, who is appointed by the WHA on the nomination of the Executive Board. The head of each regional office is a Regional Director. Regional directors are appointed by the Executive Board in agreement with the relevant regional committee.
Unitaid is a global health agency engaged in finding innovative solutions to prevent, diagnose and treat diseases more quickly, cheaply and effectively, in low- and middle-income countries. Our work includes funding initiatives to address major diseases such as HIV/AIDS, malaria and tuberculosis, as well as HIV co-infections and co-morbidities such as cervical cancer and hepatitis C, and cross-cutting areas, such as fever management.
Unitaid is now applying its expertise to address challenges in advancing new therapies and diagnostics for the COVID-19 pandemic, serving as a key member of the Access to COVID Tools Accelerator. Unitaid is hosted by the World Health Organization.
Purpose of the Request for Proposal (RFP)
The purpose of this RFP is to enter into a contractual agreement with a successful bidder and select a suitable Contractor to carry out evaluation of Unitaid’s portfolio of COVID-19 investments.
The works (evaluation) will run over the span of three months from June 2021 and that the core phase of data collection and analysis will occur in June and July 2021. The aim is to present a final report to the Unitaid Secretariat in mid-September 2021.
Bidders are invited to submit a proposal for the above mentioned Request for Proposal in accordance with the tender documents. Kindly pay attention to below tender timeline:
1) No later than 23 April 2021 17h00 Geneva time, bidder shall complete and return, under “Correspondence” tab of UNGM (paragraph 4.2 of the Request for Proposals refer):
a) The enclosed Acknowledgement Form (Annex 1 of the Request for Proposals) duly completed and signed as confirmation of bidder’s intention to submit a bona fide proposal and designate the bidder’s representative to whom communications may be directed, including any addenda; and
b) The enclosed Confidentiality Undertaking form (Annex 2 of the Request for Proposals) signed.
2) A prospective bidder requiring any clarification on technical, contractual or commercial matters may submit its questions via UNGM “Correspondence” tab no later than 19 April 2021 17h00 Geneva time and formulate them as follows:
Question # Reference to RFP (paragraph #) Question text
The Unitaid team will respond in writing (via the “Correspondence” tab of UNGM) to any request for clarification of the RFP that it receives prior to the date mentioned in the Request for Proposals (paragraph 4.6).
A consolidated document of WHO’s response to all questions (including an explanation of the query but without identifying the source of enquiry) will be published on the UNGM. Paragraph 4.6 of the Request for Proposals refer.
3) Proposals must be uploaded via UNGM no later than 29 April 2021 at 17:00 hours, Geneva time (paragraph 4.11 of the Request for Proposals refer).
Objective of the consultancy:
The primary objective of this evaluation is to make an independent assessment of Unitaid’s response to the global public health crisis within the ACT-A framework, review the underlying theories of change and identify lessons learned to shape subsequent rounds of investments. The assessment will focus on strategic relevance, internal and external coherence, efficiency, effectiveness and sustainability / scalability of Unitaid’s investments. 13 investments are within scope of this evaluation.
Qualification of Firm and Consultants:
Bidders will propose a multi-disciplinary team of experienced evaluators, including a team leader. The team leader must have at least 7 years of experience leading evaluations of a similar scope and complexity and a strong understanding of the global health landscape and the challenges to equitable access, particularly in emergency settings. Core team members should have at least five years of individual experience in their respective areas of technical expertise.
The proposed evaluation team should meet the following requirements:
- Experience conducting multi-investment/intervention/grant reviews in the field of global health, with a focus on innovation and catalytic investments;
- Demonstrable ability to connect higher level (global) objectives with those at the operational/grant level and to synthesize findings/recommendations at a portfolio (aggregate) level;
- Experience in evaluating interventions, with a focus on resource limited settings, in response to previous public health emergencies;
- Substantive knowledge of access issues to health products (diagnostics, medicines, equipment) in resource limited settings – challenges and options;
- Substantive knowledge of global coordination efforts put in place as a response to the pandemic;
- Include an appropriate representation with regard to sex, a broad mix of backgrounds, skills and perspectives, and national and international experience, including in resource-limited settings;
- Proficiency in English and French (knowledge of other UN languages an asset); final deliverables must be submitted in English
Desirable
- Knowledge of COVID-19 epidemiology, diagnostic and treatment landscape;
- At least one team member with expertise in working in health emergencies;
- Bidders have local presence or access to local experts/counterparts in (select) countries where Unitaid-funded COVID work is being implemented: South Africa, Burkina Faso, Guinea, Senegal, Kenya, Tanzania.
It is expected that work under this evaluation will take place entirely remotely. If the COVID-19 context permits that some consultations take place in person, then that can be considered.
Documents
In order to access the RFP documents, please log-in as a registered Supplier (Account registration accessible on https://www.ungm.org/Account/Registration).
If you experience difficulties in accessing the RFP documents after having registered and expressed interest, please send an email to: unitaid-proc@who.int.
Verified user
Related Ads
Some other Request for Proposal ads that you might be interested in...
Website Reconstruction Services
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the “Global Fund”) invites all potential suppliers (the “Bidders”) to submit proposals for the above-captioned Request […]
2022-02-23
Provision of Freight Invoices Audit Services
The United Nations Children’s Fund (UNICEF) was created by the United Nations General Assembly on 11 December 1946, to provide emergency food and healthcare to children in […]
2019-10-15
Procurement of Removal of household goods and personal effects, shipping an...
The Food and Agriculture Organization of the United Nations (FAO) has launched a new Request for Proposal for the “Removal of household goods and personal […]
2019-04-12
















